Status:
ACTIVE_NOT_RECRUITING
Newborn Abdominal Massage to Prevent Hyperbilirubinemia
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Newborn Jaundice
Eligibility:
All Genders
Up to 48 years
Phase:
NA
Brief Summary
The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
Eligibility Criteria
Inclusion
- Newborn admitted to the well newborn/postpartum care unit at UC Davis Medical Center
- Less than 48 hours of age at enrollment
Exclusion
- Infant has already received phototherapy
- Mother/birthing person is incarcerated
- Infant unexpected to discharge into parental care
- Parental inability to speak or read in English
- Infant without parent rooming-in with them in the hospital
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05282394
Start Date
August 1 2022
End Date
June 30 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California-Davis
Sacramento, California, United States, 95817